| Literature DB >> 24933002 |
Aneta Mirecka1, Katarzyna Paszkowska-Szczur2, Rodney J Scott3, Bohdan Górski2, Thierry van de Wetering2, Dominika Wokołorczyk2, Tomasz Gromowski2, Pablo Serrano-Fernandez2, Cezary Cybulski2, Aniruddh Kashyap2, Satish Gupta4, Adam Gołąb5, Marcin Słojewski5, Andrzej Sikorski5, Jan Lubiński2, Tadeusz Dębniak2.
Abstract
The genetic basis of prostate cancer (PC) is complex and appears to involve multiple susceptibility genes. A number of studies have evaluated a possible correlation between several NER gene polymorphisms and PC risk, but most of them evaluated only single SNPs among XP genes and the results remain inconsistent. Out of 94 SNPs located in seven XP genes (XPA-XPG) a total of 15 SNPs were assayed in 720 unselected patients with PC and compared to 1121 healthy adults. An increased risk of disease was associated with the XPD SNP, rs1799793 (Asp312Asn) AG genotype (OR=2.60; p<0.001) and with the AA genotype (OR=531; p<0.0001) compared to the control population. Haplotype analysis of XPD revealed one protective haplotype and four associated with an increased disease risk, which showed that the A allele (XPD rs1799793) appeared to drive the main effect on promoting prostate cancer risk. Polymorphism in XPD gene appears to be associated with the risk of prostate cancer.Entities:
Keywords: Cancer; Polymorphism; Prostate; SNP; Xeroderma pigmentosum
Mesh：
Substances：
Year: 2014 PMID： 24933002 DOI： 10.1016/j.gene.2014.06.026
Source DB: PubMed Journal: Gene ISSN： 0378-1119 Impact factor: 3.688